Exponent, Inc. EXPO | NASDAQ

$75.70 -$2.13 | -2.73%

Company Overview:

Market Cap: $3.84B
PE Ratio: 35.87
52-Week Range: $73.37 - $115.75
Dividend Yield (FWD): 1.54% ($1.20)

6.3 Year Performance Metrics:

Total Return (with DRIP): 66.23% (8.40% / yr)
Total Return (no DRIP): 67.01% (8.48% / yr)
Share Price: 55.76%
Dividend Increase: 87.50
EXPO 6.3-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

EXPO Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
EXPO Dividend CAGR:1Y: 7.14%2Y: 7.42%5Y: 9.57%10Y: 14.87%
Share Price
EXPO Price CAGR:1Y: -15.27%2Y: -7.78%5Y: 3.04%10Y: 4.53%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

EXPO Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - EXPO
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - EXPO
14-Day FREE Trial Get Full Access Now!

EXPO Earnings, Revenue, Cash & Debt, Shares Outstaning:

EXPO - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
EXPO - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
EXPO - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
EXPO - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
EXPO - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
EXPO - Cash & Debt
14-Day FREE Trial Get Full Access Now!
EXPO - Revenue
14-Day FREE Trial Get Full Access Now!
EXPO Revenue CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
EXPO EPS CAGR:1Y: -19.30%2Y: -4.08%5Y: 8.21%10Y: 7.65%
EXPO - Net Income
14-Day FREE Trial Get Full Access Now!
EXPO Net Income CAGR:1Y: -19.29%2Y: -4.28%5Y: 7.61%10Y: 7.27%
EXPO - EBITDA
14-Day FREE Trial Get Full Access Now!
EXPO EBITDA CAGR:1Y: -28.71%2Y: -4.49%5Y: 24.48%10Y: 3.84%
EXPO - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
EXPO Free Cash Flow CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
EXPO Free Cash Flow / Share CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Gross Profit
14-Day FREE Trial Get Full Access Now!
EXPO Gross Profit CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Expenses
14-Day FREE Trial Get Full Access Now!
EXPO Expenses CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
EXPO Shares Outstanding CAGR:1Y: 0.26%2Y: -0.04%5Y: -0.57%10Y: -0.58%
EXPO - Share Buybacks
14-Day FREE Trial Get Full Access Now!
EXPO Share Buybacks CAGR:1Y: -100.00%2Y: 0.00%5Y: -100.00%10Y: -100.00%
EXPO - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
EXPO Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Dividends
14-Day FREE Trial Get Full Access Now!
EXPO Dividend CAGR:1Y: 7.14%2Y: 7.42%5Y: 9.57%10Y: 14.87%
EXPO - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
EXPO Revenue CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

EXPO - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
EXPO Actual Revenue CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
EXPO Actual EPS CAGR:1Y: -19.30%2Y: -4.08%5Y: 8.21%10Y: 7.65%
EXPO - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
EXPO Actual Net Income CAGR:1Y: -19.29%2Y: -4.28%5Y: 7.61%10Y: 7.27%
EXPO - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
EXPO Actual EBITDA CAGR:1Y: -28.71%2Y: -4.49%5Y: 24.48%10Y: 3.84%

Ratios, Profit Margins & Return on Capital:

EXPO - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
EXPO Net Profit Margin CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
EXPO Gross Profit Margin CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
EXPO - Price to Earnings
14-Day FREE Trial Get Full Access Now!
EXPO - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
EXPO - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
EXPO - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

EXPO Dividends Info:

Annual Dividend: $1.20
Forward Yield: 1.59%
Ex-Dividend Date: 2025-03-07
Lifetime Dividens / Share: $7.62

EXPO Dividend History: Dates, Payments & Yield list

Below is a schedule of all EXPO dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
03/07/202503/21/2025$0.3001.33%1.4%$85.54
12/06/202412/20/2024$0.2801.17%1.17%$95.60
09/06/202409/20/2024$0.2801.07%1.09%$102.58
06/07/202406/21/2024$0.2801.16%1.2%$93.48
03/07/202403/22/2024$0.2801.31%1.39%$80.82
12/07/202312/22/2023$0.2601.25%1.25%$83.00
09/07/202309/22/2023$0.2601.14%1.17%$89.10
06/08/202306/23/2023$0.2601.04%1.08%$96.29
03/09/202303/24/2023$0.2600.96%1.02%$101.95
12/08/202212/23/2022$0.2400.93%0.93%$103.50
09/08/202209/23/2022$0.2400.97%1.02%$94.47
06/09/202206/24/2022$0.2401.01%1.1%$87.13
03/10/202203/25/2022$0.2400.87%1%$96.38
12/02/202112/17/2021$0.2000.67%0.67%$118.98
09/09/202109/24/2021$0.2000.69%0.69%$115.15
06/10/202106/25/2021$0.2000.88%0.9%$88.59
03/11/202103/26/2021$0.2000.77%0.8%$99.73
12/03/202012/18/2020$0.1900.93%0.93%$81.82
09/10/202009/25/2020$0.1900.95%0.99%$76.95
06/11/202006/26/2020$0.1900.95%1.03%$74.01
03/12/202003/27/2020$0.1901.02%1.16%$65.75
12/05/201912/20/2019$0.1600.99%0.99%$64.94
09/05/201909/20/2019$0.1600.86%0.9%$70.83
06/06/201906/21/2019$0.1601%1.11%$57.87
03/07/201903/22/2019$0.1600.98%1.14%$56.28
12/06/201812/21/2018$0.1300%0%$0.00
09/06/201809/21/2018$0.1300%0%$0.00
06/07/201806/22/2018$0.1300%0%$0.00
03/01/201803/23/2018$0.1300%0%$0.00
11/30/201712/22/2017$0.1050%0%$0.00
08/30/201709/22/2017$0.1050%0%$0.00
06/07/201706/23/2017$0.1050%0%$0.00
03/01/201703/24/2017$0.1050%0%$0.00
11/30/201612/23/2016$0.0900%0%$0.00
08/31/201609/23/2016$0.0900%0%$0.00
06/08/201606/24/2016$0.0900%0%$0.00
03/02/201603/25/2016$0.0900%0%$0.00
11/24/201512/18/2015$0.0750%0%$0.00
09/02/201509/25/2015$0.0750%0%$0.00
06/10/201506/26/2015$0.0750%0%$0.00
03/04/201503/27/2015$0.0750%0%$0.00
11/25/201412/19/2014$0.0630%0%$0.00
09/03/201409/26/2014$0.0630%0%$0.00
06/04/201406/27/2014$0.0630%0%$0.00
03/05/201403/28/2014$0.0630%0%$0.00
11/26/201312/20/2013$0.0380%0%$0.00
09/04/201309/27/2013$0.0380%0%$0.00
06/05/201306/28/2013$0.0380%0%$0.00
03/06/201303/29/2013$0.0380%0%$0.00

Projected Future Returns & Dividends for EXPO

Based on past 6.3-year performance, here are EXPO growth metrics:

Share price CAGR of +7.29%
Dividend CAGR of +14.89%

Using EXPO CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

EXPO (DRIP)EXPO - No DRIP
Current Price$77.82$77.82
Start Shares128.50128.50
Start Value$10,000$10,000
  
After 10 years:
Final Share Count159.06128.50
Dividends Payment$1.20$1.20
Annual Dividends$765$618
Yield on cost7.65%6.18%
Share Price$146.57$146.57
Total Dividends$3,503$3,115
Final Value$23,314$21,949

Estimated Future Value + Dividends - EXPO

NOTE: Above numbers are our estimate based on EXPO's Dividend and Price CAGR over past 6.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Exponent, Inc. (EXPO) had its IPO on 1990-08-17, and is trader on NASDAQ stock exchange.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

EXPO website: https://www.exponent.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial